Bardia, A., Cameron, J., Venkatesan, K., Robinson, D., Porter, D., Kim, S., Parton, M., Kümmel, S., Estevez, L., Huang, C., Cortes Castan, J., Ruiz-Borrego, M., Telli, M., Martín Martorell, P., Lopez, R., Beck, J., Ismail-Khan, R., Chen, S., Hurvitz, S., & Mayer, I. (n.d.). 1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC). European journal of cancer, 51, S326–. http://access.bl.uk/ark:/81055/vdc_100030628203.0x00003a